Amphotericin B
Back to searchMolecule Structure
Scientific Name
Amphotericin B
Description of the Drug
Amphotericin B is an antifungal used to treat fungal infections in neutropenic patients, cryptococcal meningitis in HIV infection, fungal infections, and leishmaniasis.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00681
http://www.drugbank.ca/drugs/DB00681
Brand Name(s)
Abelcet, Ambisome, Amophotericin B, Ampho-moronal, Amphotec, Amphotercin B, Amphotericin b, Amphotericine B, Amphotericitin B, Amphotreicin B, Ampotericin B, Fungilin, Fungilin in orabase, Fungizone
Company Owner(s)
Sun Pharma Industries Ltd, Bristol Myers Squibb Co, Apothecon Inc Div Bristol Myers Squibb, Abraxis Pharmaceutical Products, Astellas Pharma Us Inc, Teva Parenteral Medicines Inc, Xgen Pharmaceuticals Djb Inc, Abbott Laboratories, Leadiant Biosciences Inc, Alkopharma Usa Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Ergosterol | SMALL MOLECULE | SEQUESTERING AGENT | CHEMBL2364028 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL17973 | |||||
| PharmGKB | PA448415 | |||||
| Human Metabolome Database | HMDB0014819 | |||||
| DrugBank | DB00681 | |||||
| PubChem: Thomson Pharma | 14889787 | 14791931 | ||||
| PubChem | 5280965 | 91819969 | ||||
| NMRShiftDB | 60058697 | |||||
| BindingDB | 50457967 | |||||
| EPA CompTox Dashboard | DTXSID9022601 | |||||
| LipidMaps | LMPK06000002 | |||||
| DrugCentral | 197 | |||||
| Metabolights | MTBLC2682 | |||||
| Brenda | 240153 | 32851 | 50632 | 5518 | ||
| ChemicalBook | CB3425912 | |||||
| rxnorm | AMPHOTERICIN B | AMPHOTERICIN | ABELCET | AMPHOTERICIN B LIPID COMPLEX | AMBISOME | AMPHOTERICIN B LIPOSOMAL |
| PubChem: Drugs of the Future | 12012606 | |||||
| KEGG Ligand | C06573 | |||||
| ChEBI | 2682 | |||||
| ZINC | ZINC000253387843 |
